The prognostic implications and tumor-suppressive functions of CYR61 in estrogen receptor-positive breast cancer

Due to the therapeutic resistance of endocrine therapy and the limited efficacy of immune checkpoint inhibitors in estrogen receptor (ER)-positive breast cancer (BRCA), there is an urgent need to develop novel prognostic markers and understand the regulation of the tumor immune microenvironment (TIM...

Full description

Bibliographic Details
Main Authors: Cheng Zhang, Zhihua Li, Kaiheng Hu, Yifei Ren, Haoran Zhang, Yuankang Zhao, Wenjing Wei, Shuo Tu, Xiaohua Yan
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1308807/full